Portfolio company
CardioDx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company produces a genomic blood test for clinicians to assess the likelihood of obstructive coronary artery disease in symptomatic, non-diabetic patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CardiNor
This company develops secretoneurin blood assays for laboratories and researchers to assess risk in patients with cardiovascular disease.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
GeneDx
This company provides genomic testing and diagnostic services for rare and inherited diseases to healthcare providers, hospitals and pharmaceutical partners.
Boston Heart Diagnostics
The company provides cardiovascular diagnostic tests and personalised nutrition programmes to healthcare providers and patients to manage heart disease risk.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
LipoScience
This company develops nuclear magnetic resonance diagnostic tests and clinical analysers for laboratories and physicians to manage patient cardiovascular and metabolic disease risks.
Genetesis
This company develops non-invasive biomagnetic imaging systems to help emergency departments and cardiologists diagnose cardiovascular disease and triage chest pain.
Ischemia Technologies
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
